Evolving inclusion criteria in early manifest Huntington’s disease (HD) to address striatal atrophy: Lessons from HD-GeneTRX-1, the first gene therapy trial
Objective: To describe the early screening experience and evidence-based adaptations to the inclusion criteria for HD-GeneTRX-1 (NCT04120493). Background: AMT-130 is an AAV5-based gene therapy intended…Role of the Stereotactic Dentatotomy for the management of Movement Disorders
Objective: Evaluate the antecedents about the clinical outcomes of stereotactic dentatotomy in the management of diverse motor disorders. Background: The dentatotomy is a surgical technique…A retrospective analysis of Movement Disorder Patient Referrals for Functional Neurosurgery in the Neurosciences Department of Mater Dei Hospital
Objective: Malta has a population of just under 450 000. The estimated number of patients likely to benefit from functional neurosurgery including Deep Brain Stimulation…Anodic stimulation reduces corticospinal tract engagement in STN-DBS for Parkinson’s disease: a case report.
Objective: To seek how novel programming options modify the therapeutic window in a case of off-targeting DBS. Background: In Parkinson’s disease deep brain stimulation (DBS)…Deep Brain Stimulation of Anterior Globus Pallidus internus Reduces Impulsivity in Parkinson’s Disease
Objective: To evaluate whether selective deep brain stimulation (DBS) stimulation of anterior region of globus pallidus internus (GPi) affects impulsivity in Parkinson’s Disease patients Background:…Autoimmunity may contribute to peri-electrode edema after deep brain stimulation for Parkinson’s disease: a case series
Objective: To identify and characterize cases of symptomatic peri-electrode edema after DBS. Background: Peri-electrode edema is a rare complication of Deep Brain Stimulation (DBS) surgery.…BILATERAL SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A PATIENT WITH PARKINSON DISEASE AND INTOLERANCE TO STANDARD ANTIPARKINSONIAN DRUGS – A CASE REPORT
Objective: We present a case of a 59-year-old PD patient with severe intolerance to the standard anti-Parkinsonian drugs (APDs) including levodopa (L-DOPA), MAO-B inhibitors, and…Differential patterns of gray matter volume in responders and non-responders with Parkinson’s disease after deep brain stimulation
Objective: To identify the patterns of gray matter volume by voxel-based morphometry (VBM) in responders and non-responders with Parkinson’s disease (PD) after deep brain stimulation…Focused ultrasound subthalamotomy in Parkinson’s disease: Lesion topography and improvement in cardinal motor features
Objective: To describe the topography of unilateral subthalamic nucleus (STN) lesions performed by magnetic-resonance guided focused ultrasound (MRgFUS) in Parkinson’s disease (PD), and define correlations…The clinical utility of programming method for multi-contact electrodes of deep brain stimulation in Parkinson’s disease
Objective: Consider the clinical utility of programming method for multi-contact electrodes in Parkinson’s disease (PD) from our experiences. Background: Some PD patients with deep brain…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 11
- Next Page »